                </a></li></ul></div><p><strong>Figure 6.  <span>DFS (232 cases) for TAM treated patients with breast carcinomas categorised according to the combinations in all evaluated cases of (A) ErbB-3 and ERÎ²1 expression, (B) ErbB-3 and P-Akt expression.</span></strong></p><a id="article1.body1.sec2.sec4.fig2.caption1.p1" name="article1.body1.sec2.sec4.fig2.caption1.p1"></a><p>Survival curves were generated according to the Kaplan-Meier method; statistical comparisons were made using the log-rank test.</p>
